Get the Stockscreener App
1.19
0.00%
0.01
Standard Biotools Inc stock is traded at $1.19, with a volume of 319.52K.
It is up +0.00% in the last 24 hours and down -10.45% over the past month.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
See More
Previous Close:
$1.20
Open:
$1.2
24h Volume:
319.52K
Relative Volume:
0.24
Market Cap:
$456.48M
Revenue:
$106.34M
Net Income/Loss:
$-74.66M
P/E Ratio:
-1.2526
EPS:
-0.95
Net Cash Flow:
$-46.12M
1W Performance:
-9.09%
1M Performance:
-10.45%
6M Performance:
+0.00%
1Y Performance:
-39.70%
1-Day Range:
$1.19
$1.225
1-Week Range:
$1.12
$1.34
52-Week Range:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Name
Standard Biotools Inc
Sector
Industry
Phone
(650) 266-6000
Address
2 TOWER PLACE, SOUTH SAN FRANCISCO
Compare LAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.195 | 458.39M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
122.78 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.63 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
357.15 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.22 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.85 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-27-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-24 | Initiated | TD Cowen | Buy |
| Apr-04-24 | Initiated | Jefferies | Buy |
| Jul-12-23 | Initiated | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Stock (LAB) Latest News
Earnings To Watch: Standard BioTools Inc (LAB) Reports Q3 2025 R - GuruFocus
Understanding Standard BioTools Inc.’s price movementIPO Watch & Target Return Focused Picks - newser.com
How Standard BioTools Inc. stock performs in interest rate cyclesQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Why Standard BioTools Inc. (FLB) stock is upgraded to buyBuy Signal & Momentum Based Trading Signals - newser.com
Analyzing net buyer seller activity in Standard BioTools Inc.July 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com
Can momentum traders help lift Standard BioTools Inc.Earnings Risk Summary & AI Forecast for Swing Trade Picks - newser.com
Top chart patterns to watch in Standard BioTools Inc.Buy Signal & Low Drawdown Trading Strategies - newser.com
Is Mahasagar Travels Limited Stock a Core Holding or a Speculative PlayCup and Handle Formations & Technical + Fundamental = Smarter Investing - earlytimes.in
Standard BioTools Inc. recovery potential after sell off2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com
Why Standard BioTools Inc. (FLB) stock gets analyst attentionWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Is Standard BioTools Inc. stock cheap compared to fundamentalsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.7%Time to Sell? - MarketBeat
Standard BioTools' (LAB) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Standard Biotools Inc Stock (LAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):